• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Tatva Share Price

    Tatva Chintan Pharma Chem Share PriceTatva Chintan Pharma Chem

    Small Cap 5.3k Result
    ₹1,564.95
    57.2 (3.79%)
    • Advice
    • Hold
    As on 02 December, 2023 | 00:31 BSE: 543321 NSE: TATVAISIN: INE0GK401011

    Tatva Chintan Pharma Chem Performance

    Day Range

    • Low 1,516.05
    • High 1,586.00
    ₹ 1,564.95

    52 Week Range

    • Low 1,399.90
    • High 2,323.00
    ₹ 1,564.95
    • Open Price1,520.00
    • Previous Close1,507.75
    • Volume65475

    Start SIP in Tatva Chintan Pharma Chem

    Start SIP

    Tatva Chintan Pharma Chem Share Price

    • Over 1 Month 7.95%
    • Over 3 Month -9.13%
    • Over 6 Month -5.4%
    • Over 1 Year -30.07%

    Tatva Chintan Pharma Chem Key Statistics

    P/E Ratio 79.8
    PEG Ratio -4
    Market Cap Cr 3,661
    Price to Book Ratio 7.1
    EPS 18.8
    Dividend 0.1
    Relative Strength Index 63.63
    Money Flow Index 66.13
    MACD Signal -11.7
    Average True Range 42.08

    Tatva Chintan Pharma Chem Investment Rating

    • Master Rating:

    • Tatva Chintan Pharma Chem has an operating revenue of Rs. 456.15 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 70 indicates it belongs to a poor industry group of Chemicals-Basic and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Tatva Chintan Pharma Chem Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 931061191148486102
    Operating Expenses Qtr Cr 728610497757380
    Operating Profit Qtr Cr 2120151791322
    Depreciation Qtr Cr 7632222
    Interest Qtr Cr 3332111
    Tax Qtr Cr 43-93231
    Net Profit Qtr Cr 8816115919
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 409438
    Operating Expenses Annual Cr 348322
    Operating Profit Annual in Cr 55106
    Depreciation Cr 108
    Interest Annual Cr 85
    Tax Annual Cr -27
    Net Profit Annual Cr 4096
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2420
    Cash from Investing Activity Annual Cr -101-197
    Cash from Financing Annual Activity Cr 38235
    Net Cash Flow Annual Cr -4058
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 505469
    Fixed Assets Annual Cr 427211
    Total Non Current Assets Annual Cr 443223
    Total Current Assets Annual Cr 311429
    Total Assets Annual Cr 755652
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 228212
    ROE Annual % 820
    ROCE Annual % 1022
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1527
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 97114125121908899
    Operating Expenses Qtr Cr 7693108103797377
    Operating Profit Qtr Cr 20211618111522
    Depreciation Qtr Cr 7632222
    Interest Qtr Cr 3333111
    Tax Qtr Cr 34-93241
    Net Profit Qtr Cr 810171271018
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 429443
    Operating Expenses Annual Cr 363325
    Operating Profit Annual in Cr 61108
    Depreciation Cr 108
    Interest Annual Cr 85
    Tax Annual Cr -18
    Net Profit Annual Cr 4596
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2820
    Cash from Investing Activity Annual Cr -101-197
    Cash from Financing Annual Activity Cr 38235
    Net Cash Flow Annual Cr -3659
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 515473
    Fixed Assets Annual Cr 427211
    Total Non Current Assets Annual Cr 443222
    Total Current Assets Annual Cr 314436
    Total Assets Annual Cr 756658
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 232213
    ROE Annual % 920
    ROCE Annual % 1122
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1627
    Invest in Tatva Chintan Pharma Chem

    Tatva Chintan Pharma Chem Technicals

    EMA & SMA

    Current Price
    ₹1,564.95
    57.2 (3.79%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹1,499.30
    • 50 Day
    • ₹1,532.01
    • 100 Day
    • ₹1,594.00
    • 200 Day
    • ₹1,715.79
    • 20 Day
    • ₹1,492.34
    • 50 Day
    • ₹1,525.53
    • 100 Day
    • ₹1,606.91
    • 200 Day
    • ₹1,680.43

    Tatva Chintan Pharma Chem Resistance and Support

    PIVOT
    ₹1,555.67
    Resistance
    First Resistance 1,595.28
    Second Resistance 1,625.62
    Third Resistance 1,665.23
    RSI 63.63
    MFI 66.13
    MACD Single Line -11.70
    MACD -2.96
    Support
    First Resistance 1,525.33
    Second Resistance 1,485.72
    Third Resistance 1,455.38

    Tatva Chintan Pharma Chem Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 76,451 4,209,392 55.06
    Week 32,606 1,921,116 58.92
    1 Month 19,234 1,161,148 60.37
    6 Month 36,006 2,401,572 66.7

    Tatva Chintan Pharma Chem Result Highlights

    Tatva Chintan Pharma Chem Synopsis

    NSE-Chemicals-Basic

    Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 403.04 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2023. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
    Market Cap 3,668
    Sales 432
    Shares in Float 0.65
    No of funds 39
    Yield 0.14
    Book Value 6.62
    U/D Vol ratio 0.4
    LTDebt / Equity 1
    Alpha -0.19
    Beta 0.74

    Tatva Chintan Pharma Chem

    Owner NameSep-23Aug-23Jun-23Mar-23
    Promoters 72.02%75.02%79.17%79.17%
    Mutual Funds 13.54%13.57%10.76%10.98%
    Insurance Companies 0.11%0.11%0.12%0.53%
    Foreign Portfolio Investors 4.4%4.13%3.19%3.54%
    Individual Investors 8.72%6.23%5.91%5.09%
    Others 1.21%0.94%0.85%0.69%

    Tatva Chintan Pharma Chem Management

    Name Designation
    Mr. Chintan Nitinkumar Shah Chairman & Managing Director
    Mr. Ajaykumar Mansukhlal Patel Whole Time Director
    Mr. Shekhar Rasiklal Somani Whole Time Director
    Dr. Manher Chimanlal Desai Independent Director
    Mr. Subhash Ambubhai Patel Independent Director
    Dr. Avani Rajesh Umatt Independent Director

    Tatva Chintan Pharma Chem Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Tatva Chintan Pharma Chem Corporate Action

    Date Purpose Remarks
    2023-11-02 Quarterly Results
    2023-08-04 Quarterly Results
    2023-07-11 Preferential issue of shares
    2023-05-05 Audited Results & Final Dividend
    2023-01-24 Quarterly Results
    Date Purpose Remarks
    2022-09-09 FINAL Rs.2.00 per share(20%)Final Dividend

    Tatva Chintan Pharma Chem MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 37,319
    SBI Magnum Midcap Fund Regular Growth 13,202
    Nippon India ELSS Tax Saver Fund Growth 12,323
    Mirae Asset Hybrid-Equity Fund -Regular Plan-Growth 7,611
    ICICI Prudential Smallcap Fund Growth 6,003

    Tatva Chintan Pharma Chem FAQs

    What is Share Price of Tatva Chintan Pharma Chem ?

    Tatva Chintan Pharma Chem share price is ₹1,564 As on 02 December, 2023 | 00:17

    What is the Market Cap of Tatva Chintan Pharma Chem ?

    The Market Cap of Tatva Chintan Pharma Chem is ₹3660.7 Cr As on 02 December, 2023 | 00:17

    What is the P/E ratio of Tatva Chintan Pharma Chem ?

    The P/E ratio of Tatva Chintan Pharma Chem is 79.8 As on 02 December, 2023 | 00:17

    What is the PB ratio of Tatva Chintan Pharma Chem ?

    The PB ratio of Tatva Chintan Pharma Chem is 7.1 As on 02 December, 2023 | 00:17

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.